|
시장보고서
상품코드
1880567
모바일 헬스(mHealth) 각종 기술과 세계 시장Mobile Health (mHealth) Technologies and Global Markets |
||||||
세계 모바일 헬스(mHealth) 기술 시장 규모는 2025년 914억 달러 규모에서 2025-2030년의 예측 기간 동안 연평균 17.1% 성장하여 2030년 말에는 2,011억 달러 규모에 이를 것으로 예측됩니다.
북미 시장은 2025년 334억 달러에서 2025-2030년의 예측 기간 동안 CAGR 18.6%로 성장하여 2030년 말에는 784억 달러에 달할 것으로 예측됩니다. 아시아태평양 시장은 2025년 234억 달러에서 2025-2030년의 예측 기간 동안 19.7%의 연평균 복합 성장률(CAGR)로 성장하여 2030년 말에는 579억 달러에 달할 것으로 예측됩니다.
세계의 모바일 헬스(mHealth) 기술과 시장에 대해 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 기술 동향, 법 및 규제 환경, 시장 규모 추이 및 예측, 각종 부문별/지역별 상세 분석, 주요 기업 개요 등의 정보를 전해드립니다.
The global market for Mobile Health (mHealth) Technologies is expected to grow from $91.4 billion in 2025 and is projected to reach $201.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 17.1% during the forecast period of 2025 to 2030.
The North American market for mHealth Technologies is expected to grow from $33.4 billion in 2025 and is projected to reach $78.4 billion by the end of 2030, at a CAGR of 18.6% during the forecast period of 2025 to 2030.
The Asia-Pacific market for mHealth Technologies is expected to grow from $23.4 billion in 2025 and is projected to reach $57.9 billion by the end of 2030, at a CAGR of 19.7% during the forecast period of 2025 to 2030.
This report provides an overview of the global mobile health (mHealth) technologies market and analyzes market trends. It includes global revenue ($ million) for the base year of 2024 and estimated data for 2025 and the forecast period 2026 through 2030. The market is segmented based on type, end-user industry, and region. The regions covered in this study include North America, Europe, Asia-Pacific, Middle East and Africa (MEA), and South America, focusing on major countries in these regions.
The report discusses mobile health (mHealth) technologies and their various resources. It covers the mobile health (mHealth) technologies market, including medical devices, apps, and services. The report further analyzes the market based on medical devices, analyzing blood pressure monitors, blood glucose meters, ECG/heart rate monitors, pulse oximeters, peak flowmeters, sleep apnea monitors, multiparameter trackers, fetal monitoring, neurological monitoring devices, and other connected medical devices. The report also analyzes various medical apps, including chronic care management apps, general health and fitness apps, medication management apps, patient management and monitoring apps, personal health record apps, and women's health apps, among others. A complete regional analysis of the market was also conducted for this report.
This report provides a detailed analysis of AI adoption and use cases in mobile health (mHealth) technologies and highlights geographic trends across North America, Europe, Asia-Pacific, South America and MEA. It also examines AI disruption across industry verticals and value chain stages, while presenting market spending patterns, investment forecasts, major company expenditures, and venture capital funding in AI-driven mHealth technologies.
The report examines the environmental, social, and corporate governance (ESG) factors influencing the adoption and ethical use of mHealth solutions. It assesses how sustainability practices, equitable access, and responsible data management shape market growth and industry trust. The report also reviews recent patent filings and innovation trends, highlighting advances in AI-driven diagnostics, remote patient monitoring, digital therapeutics, and next-generation wearable health devices. These developments underscore the market shift toward intelligent, connected, and patient-focused healthcare solutions that balance technological progress with ethical responsibility.
A comprehensive competitive landscape analysis ranks and evaluates the market shares of major players globally, highlighting their strategic initiatives, R&D investments, and technological strengths in mHealth technologies solutions. The report concludes with detailed company profiles of key market participants, offering insights into their product portfolios, partnerships, acquisitions, and contributions to the advance of AI in neurological healthcare.